The market does not like the results, but what people are not understanding is that the results for the group that didn't include non-responders are actually the same as the results reported in May (where non-responders were not part of the group). That is ,about 15% after the placebo effect is subtracted , compared to about 16% in May. That is, the group that is going to be submitted for FDA approval has been helped 15% compared to placebo. Anyway, this is my take (non-scientist)
Ann: Positive Results from the SOLVE-CRT Randomised Sub-Study, page-4
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.025(2.53%) |
Mkt cap ! $312.7M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.06 | $1.00 | $100.2K | 96.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 980 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 3180 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| EBR (ASX) Chart |